Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huoxue Qianyang Qutan Decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, affiliated with the Shanghai University of Traditional Chinese Medicine. It is specifically designed to treat patients presenting with both hypertension and abdominal obesity. The formulation's name reflects its core therapeutic principles in TCM: "Huoxue" (promoting blood circulation), "Qianyang" (subduing liver Yang), and "Qutan" (eliminating phlegm). These actions are intended to address the underlying pathological syndromes of blood stasis, hyperactivity of liver Yang, and phlegm-dampness often associated with metabolic syndrome and elevated blood pressure. The decoction has been evaluated in randomized, double-blind, placebo-controlled clinical trials to assess its clinical efficacy and safety in reducing abdominal fat and managing blood pressure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on huoxue qianyang qutan decoction.